Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas

G Ital Dermatol Venereol. 2015 Dec;150(6):755-6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / complications
  • Breast Neoplasms / drug therapy
  • Caustics / administration & dosage
  • Caustics / therapeutic use*
  • Cautery / methods*
  • ErbB Receptors / antagonists & inhibitors*
  • Female
  • Granuloma, Pyogenic / chemically induced
  • Granuloma, Pyogenic / surgery*
  • Humans
  • Lapatinib
  • Middle Aged
  • Nail Diseases / chemically induced
  • Nail Diseases / surgery*
  • Neoplasm Proteins / antagonists & inhibitors*
  • Phenol / administration & dosage
  • Phenol / therapeutic use*
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Toes

Substances

  • Antineoplastic Agents
  • Caustics
  • Neoplasm Proteins
  • Protein Kinase Inhibitors
  • Quinazolines
  • Lapatinib
  • Phenol
  • EGFR protein, human
  • ErbB Receptors